Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

VIR stock hub

Vir Biotechnology, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VIRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

VIR

In the news

Latest news · VIR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-47.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-111.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VIR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001706431
Company name	Vir Biotechnology, Inc.
Country	United States
Country code	US
Cusip	92764N102
Employees	367
Employees Change	-41%
Employees Change Percent	-10.05
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-10-11
Isin	US92764N1028
Last refreshed	2026-05-10
Market cap	$1.5B
Market cap category	Small-Cap
Price	$9.12
Price currency	USD
Rev Per Employee	178,460.49x
Sector	Healthcare
Sic	2836
Symbol	VIR
Website	https://www.vir.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.78%
EV Sales Forward	4.94x
EV/Sales	17.67x
FCF yield	-29.23%
P/B ratio	1.81x
P/S ratio	23.48x
PS Forward	6.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-371.2M
Net Income	$-442.7M
Net Income Growth Years	2%
Pretax Margin	-675.39%
Profit Per Employee	$-1.2M
ROA	-24.79
Roa5y	-4.38
ROCE	-48.6
ROE	-47.69
Roe5y	-7.75
ROIC	-111.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	62.62%
Cagr3y	-28.06%
Cagr5y	-26.66%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	213.96x
Revenue Growth Years	0x
Revenue Growth3 Y	-47.25x
Revenue Growth5 Y	-2.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.06
Assets	$1B
Cash	$476.3M
Current Assets	$523M
Current Liabilities	$73.6M
Debt	$95.6M
Debt Equity	$0.12
Equity	$812.8M
Liabilities	$212.8M
Long Term Assets	$502.6M
Long Term Liabilities	$139.3M
Net Cash	$380.7M
Net Cash By Market Cap	$24.75
Net Cash Growth	-46.04%
Net Debt Equity	$-0.47
Tangible Book Value	$788.1M
Tangible Book Value Per Share	$4.89
WACC	12.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.11
Net Working Capital	$-17.9M
Quick ratio	6.52
Working Capital	$449.4M
Working Capital Turnover	$0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.07%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	62.57%
200-day SMA	6.88
3Y total return	-62.78%
50-day SMA	9.63
50-day SMA vs 200-day SMA	50over200
5Y total return	-78.78%
All Time High	141
All Time High Change	-93.53%
All Time High Date	2021-01-27
All Time Low	4.16
All Time Low Change	119.49%
All Time Low Date	2025-08-11
ATR	0.54
Beta	1.7
Beta1y	0.8
Beta2y	0.64
Ch YTD	51.24
High	9.54
High52	11.66
High52 Date	2026-04-20
High52ch	-21.78%
Low	9.11
Low52	4.16
Low52 Date	2025-08-11
Low52ch	119.5%
Ma50ch	-5.28%
Premarket Change Percent	0.97
Premarket Price	$9.36
Premarket Volume	1,375
Price vs 200-day SMA	32.6%
RSI	40.2
RSI Monthly	49.6
RSI Weekly	57.77
Sharpe ratio	0.97x
Sortino ratio	1.74
Total Return	-3.07%
Tr YTD	51.24
Tr1m	-0.55%
Tr1w	-8.8%
Tr3m	26.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	5
Analyst Price Target Top	$20
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.38
Earnings Revenue Estimate	122,538,000x
Earnings Revenue Estimate Growth	3,941.49x
Operating Income	$-462.7M
Operating margin	-706.4
Price target	$19.43
Price Target Change	$113
Price Target Change Top	$119

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	119,230,599%
Float Percent	70.7%
Shares Insiders	4.37%
Shares Institutions	49.77%
Shares Out	168,651,974
Shares Qo Q	5.84%
Shares Yo Y	3.07%
Short Float	14.1%
Short Ratio	8.05
Short Shares	9.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-496.7M
Average Volume	1,716,237.35x
Bv Per Share	5.04
CAPEX	$-3.6M
Ch1m	-0.55
Ch1w	-8.8
Ch1y	62.57
Ch3m	26.84
Ch3y	-62.78
Ch5y	-78.78
Ch6m	77.78
Change	-1.62%
Change From Open	-2.04
Close	9.27
Days Gap	0.43
Depreciation Amortization	11,624,000
Dollar Volume	14,698,439.5
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-462.7M
EBITDA	$-451M
EPS	$-3.14
F Score	3
FCF	$-449.6M
FCF EV Yield	-38.85x
FCF Per Share	$-2.67
Financing CF	165,710,000
Fiscal Year End	December
Founded	2,016
Goodwill	16,937,000
Income Tax	$371,000
Investing CF	195,388,000
Ipr	-54.4
Iprfo	-43.53
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-23
Ma150	7.5
Ma150ch	21.57%
Ma20	10.22
Ma20ch	-10.72%
Net CF	-84,953,000
Next Earnings Date	2026-08-05
Open	9.31
Optionable	Yes
Position In Range	2.33
Ppne	113,918,000
Pre Close	9.27
Price Date	2026-05-08
Ptbv Ratio	1.95
Relative Volume	0.94x
Revenue	65,495,000x
SBC By Revenue	71.91x
Share Based Comp	47,100,000
Tax By Revenue	0.57x
Tr6m	77.78%
Us State	California
Volume	1,611,671
Z Score	-0.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VIR pay a dividend?

Capital-return profile for this ticker.

Performance

VIR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VIR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+49.8%

Float: +70.7% of shares outstanding

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VIR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.2

Neutral momentum band

Price vs 200-day MA

+32.6%

50/200-day relationship not available

Beta (5Y)

1.70

More volatile than the market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VIR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VIR stock rating?

Vir Biotechnology, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VIR analysis?

The full report lives at /stocks/VIR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VIR?

The latest report frames VIR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VIR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.